Home › Sjögren's Disease › Arizona › Tucson
Sjögren's Disease clinical trials in Tucson, AZ
3 studies for Sjögren's Disease are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Arizona Arthritis & Rheumatology Associates, P.C., Tucson
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Tucson, Tucson
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Arizona Arthritis and Rheumatology Associates - Tucson - 2001 W Orange Grove Rd, Tucson
About Sjögren's Disease
Sjögren's disease is an autoimmune disease that causes dryness of the mouth, eyes, and other parts of the body. Learn how to relieve the symptoms.
More about Sjögren's Disease on MedlinePlus
Sjögren's Disease trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Tampa, FL4 studies
- Clearwater, FL4 studies
- Cicero, IL4 studies
- Arlington, TX4 studies
- Charlotte, NC4 studies
- Oklahoma City, OK3 studies
- Memphis, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
Other studies in Tucson
- Obesity20 studies
- Breast Cancer18 studies
- Non-Small Cell Lung Cancer18 studies
- Overweight17 studies
- Metastatic Cancer14 studies
- Type 2 Diabetes13 studies
- Cancer (all types)12 studies
- Prostate Cancer12 studies
- Colorectal Cancer11 studies
- Cardiovascular Disease11 studies
- Steatotic Liver Disease10 studies
- Acute Myeloid Leukemia10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.